A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

495

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Erosive Esophagitis

Interventions

DRUG

Lafutidine

Lafutidine 20mg/day

DRUG

Famotidine

Famotidine 40mg/day

DRUG

Omeprazole

Omeprazole 20mg/day